Medpace Holdings Inc (MEX:MEDP) Stock Price, Trades & News

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Financial Strength

6/10

Name	Current	Vs Industry	Vs History
Cash-To-Debt	4.19
Equity-to-Asset	0.21
Debt-to-Equity	0.28
Debt-to-EBITDA	0.2
Interest Coverage	N/A	N/A	N/A
Piotroski F-Score	8/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	7.94	Distress Grey Safe
Beneish M-Score	-2.89	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	25.5
	3-Year EBITDA Growth Rate	28.7
	3-Year EPS without NRI Growth Rate	29.2
	3-Year FCF Growth Rate	30.3
	3-Year Book Growth Rate	9.2
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	11.63
	Future 3-5Y Total Revenue Growth Rate Estimate	8.68

Momentum Rank

5/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	100
	9-Day RSI	100
	14-Day RSI	100
	6-1 Month Momentum %	19.42
	12-1 Month Momentum %	19.42

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	0.73
	Quick Ratio	0.73
	Cash Ratio	0.35
	Days Sales Outstanding	49.9
	Days Payable	6.26

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	3
	Shareholder Yield %	1.83

Profitability Rank

10/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	28.76
	Operating Margin %	20.97
	Net Margin %	17.67
	EBITDA Margin %	21.97
	FCF Margin %	25.53
	OCF Margin %	27.17
	ROE %	125.56
	ROA %	25.9
	ROIC %	24.12
	3-Year ROIIC %	62.87
	ROC (Joel Greenblatt) %	221.5
	ROCE %	102.05
	Years of Profitability over Past 10-Year	10
	Moat Score	6
	Tariff Resilience Score	8

GF Value Rank

6/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	35.25
	Forward PE Ratio	23.63
	PE Ratio without NRI	35.25
	Shiller PE Ratio	80.97
	Price-to-Owner-Earnings	25.17
	PEG Ratio	1.09
	PS Ratio	6.23
	PB Ratio	38.68
	Price-to-Free-Cash-Flow	24.54
	Price-to-Operating-Cash-Flow	23.03
	EV-to-EBIT	28.11
	EV-to-Forward-EBIT	24.71
	EV-to-EBITDA	26.83
	EV-to-Forward-EBITDA	23.59
	EV-to-Revenue	5.89
	EV-to-Forward-Revenue	5.23
	EV-to-FCF	23.21
	Price-to-GF-Value	1.15
	Price-to-Projected-FCF	2.53
	Price-to-DCF (Earnings Based)	0.74
	Price-to-DCF (FCF Based)	0.51
	Price-to-Median-PS-Value	1.33
	Price-to-Peter-Lynch-Fair-Value	1.41
	Earnings Yield (Greenblatt) %	3.56
	FCF Yield %	4.21
	Forward Rate of Return (Yacktman) %	22.5

Financials (Next Earnings Date:2026-10-22 Est.)

Annual Quarterly TTM

MEX:MEDP's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Medpace Holdings Inc Executives

Details

GF Value™: MXN6131.53

MEX:MEDP

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 2 Medium warning signs with MEDP. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil MXN)	49,845.74
	EPS (TTM) (MXN)	305.638
	Beta	-0.0669
	3-Year Sharpe Ratio	0.55
	3-Year Sortino Ratio	1.46
	Volatility %	19.42
	14-Day RSI	100
	14-Day ATR (MXN)	0.660003
	20-Day SMA (MXN)	7022.03
	12-1 Month Momentum %	19.42
	52-Week Range (MXN)	5880 - 7022.03
	Shares Outstanding (Mil)	27.91

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	8
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Medpace Holdings Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Medpace Holdings Inc Stock Events

Financials Calendars

Event	Date	Price (MXN)
Third quarter earnings conference call for 2026	2026-10-23 09:00	In 91 days
Third quarter earnings results for 2026	2026-10-22	In 89 days
Second quarter earnings conference call for 2026	2026-07-23 09:00	7,022.03 (+0.00%)
Second quarter earnings results for 2026	2026-07-22	7,022.03 (+0.00%)
General meeting for 2026	2026-05-15 09:00	7,022.03 (+0.00%)
First quarter earnings conference call for 2026	2026-04-23 09:00	5,880.00 (+0.00%)
First quarter earnings results for 2026	2026-04-22	5,880.00 (+0.00%)
Fourth quarter earnings conference call for 2025	2026-02-10 09:00	5,880.00 (+0.00%)
Annual report for 2025	2026-02-10	5,880.00 (+0.00%)
Fourth quarter earnings results for 2025	2026-02-09	5,880.00 (+0.00%)

Show

Entries

Medpace Holdings Inc Frequently Asked Questions

What is Medpace Holdings Inc(MEX:MEDP)'s stock price today?

The current price of MEX:MEDP is MXN7022.03. The 52 week high of MEX:MEDP is MXN7022.03 and 52 week low is MXN5880.00.

When is next earnings date of Medpace Holdings Inc(MEX:MEDP)?

The next earnings date of Medpace Holdings Inc(MEX:MEDP) is 2026-10-22 Est..

Does Medpace Holdings Inc(MEX:MEDP) pay dividends? If so, how much?

Medpace Holdings Inc(MEX:MEDP) does not pay dividend.

Press Release

	Subject	Date
	Medpace Holdings, Inc. Reports Second Quarter 2026 Results	2026-07-22
	Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026	2026-06-16
	Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm	2026-06-08
	MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026	2026-06-08
	CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings (MEDP) and Upcoming Lead Plaintiff Deadline of June 8, 2026	2026-06-08
	MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP	2026-06-06
	Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit	2026-06-05
	MEDP Deadline: Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their Rights	2026-06-05
	MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm	2026-06-05
	Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP	2026-06-05

10/Page

Articles on Medpace Holdings Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.